Manufacturers Life Insurance Company, The Brooklyn Immuno Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 20, 2022
SELL
$1.76 - $4.84 $23,554 - $64,773
-13,383 Closed
0 $0
Q4 2021

Feb 16, 2022
SELL
$4.17 - $9.79 $12,793 - $30,035
-3,068 Reduced 18.65%
13,383 $56,000
Q3 2021

Nov 12, 2021
BUY
$8.86 - $17.05 $21,680 - $41,721
2,447 Added 17.47%
16,451 $153,000
Q2 2021

Aug 12, 2021
BUY
$3.75 - $78.5 $52,515 - $1.1 Million
14,004 New
14,004 $252,000

Others Institutions Holding BTX

# of Institutions
1
Shares Held
1.21M
Call Options Held
0
Put Options Held
0
View Full List

About Brooklyn ImmunoTherapeutics, Inc.

BTX Quotes by TradingView
  • Ticker BTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,825,700
  • Description
  • Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...
More about BTX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email